Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.
The norepinephrine transporter (NET) gene is an attractive candidate gene for attention-deficit hyperactivity disorder (ADHD). Noradrenergic systems are critical to higher brain functions such as attention and executive function, which are defective in ADHD. The clinical efficacy of medications that target NET also supports its role in the etiology of ADHD. Here, we have applied a dense mapping strategy to capture all genetic variations within the NET gene in a large number of ADHD families (474 trios). As a result, we found association of the same alleles from two single-nucleotide polymorphisms (rs3785143 and rs11568324) previously identified in another large-scale ADHD genetic study (International Multisite ADHD Geneproject). Furthermore, the effect sizes were consistent across both studies. This is the first time that identical alleles of NET from different studies were implicated, and thus our report provides further evidence that the NET gene is involved in the etiology of ADHD.
Kim
J W
JW
Psychiatric and Neurodevelopmental Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. ox95ford@yahoo.co.kr
Biederman
J
J
McGrath
C L
CL
Doyle
A E
AE
Mick
E
E
Fagerness
J
J
Purcell
S
S
Smoller
J W
JW
Sklar
P
P
Faraone
S V
SV
D001289:Attention Deficit Disorder with Hyperactivity / Q000235:genetics*; D001714:Bipolar Disorder / Q000235:genetics; D005190:Family; D005260:Female; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D050484:Norepinephrine Plasma Membrane Transport Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide
D050484:Norepinephrine Plasma Membrane Transport Proteins